期刊文献+

补充n-3多不饱和脂肪酸对高脂饮食大鼠肠道菌群及门静脉血内毒素的影响 被引量:5

Effect of n-3 Polyunsaturated Fatty Acids on Gut Microbiota and Endotoxin Levels in Portal Vein of Rats Fed with High-fat Diet
下载PDF
导出
摘要 目的观察补充n-3多不饱和脂肪酸(n-3PUFAs)对高脂饮食大鼠肠道菌群及门静脉血内毒素水平的影响。方法将36只雄性SD大鼠随机分为普通饮食组(CD,n=10)、高脂饮食组(HFD,n=10)、普通饮食+n-3PUFAs组(CD+n-3PUFAs,n=7)、高脂饮食+n-3PUFAs组(HFD+n-3PUFAs,n=9)4组,饲养10周后,取大鼠新鲜粪便提取DNA,采用Real-time PCR方法检测肠道菌群组成,改良偶氮基质显色鲎试剂法检测门静脉血清内毒素水平。结果饲养前,各组大鼠体重差异无统计学意义(P=0.613);饲养10周后,HFD组大鼠体重明显高于CD组(P=0.0002)、CD+n-3PUFAs组(P=0.0001)和HFD+n-3PUFAs组(P=0.022)。饲养10周后,HFD组大鼠粪便中厚壁菌门(P=0.002)和肠杆菌科(P=0.022)的含量明显高于CD组大鼠,拟杆菌门(P=0.026)和双歧杆菌属(P=0.034)含量明显低于CD组。CD+n-3PUFAs组大鼠粪便中的拟杆菌门含量明显高于CD组(P=0.043)。HFD+n-3PUFAs组大鼠粪便中的厚壁菌门含量(P=0.044)和肠杆菌科含量(P=0.012)明显低于HFD组,拟杆菌门含量明显高于HFD组(P=0.042)。饲养10周后,HFD组大鼠血内毒素水平明显高于CD组(P=0.007),HFD+n-3PUFAs组明显低于HFD组(P=0.042),CD+n-3PUFAs组与CD组差异无统计学意义(P=0.210)。结论高脂饮食可增加大鼠的体重,改变其肠道菌群。补充n-3PUFAs可以部分修复这种改变,并降低门静脉血中内毒素水平,减少体重。 Objective To investigate the effect of n-3 polyunsaturated fatty acids (n-3PUFAs) on gut microbiota and endotoxin levels in portal vein of rats fed with a high-fat diet (HFD). Methods Thirty-six male Sprague-Dawley rats were randomly divided into four groups and fed with normal control diet ( CD), HFD, CD supplemented with n-3PUFAs, and HFD supplemented with n-3PUFAs, respectively. Fresh fecal samples were collected to analyze the gut microbiota 10 weeks after feeding. DNA was exacted from the fresh fecal samples. Quantitative PCR was used to detect the composition of the gut microbiota. The endotoxin levels were detected through modified azo chromogenic substrate limulus amebocyte lysate assay. Results The differences in body weight before breeding in each group were not statistically significant among these four groups ( P = 0. 613 ) . The increase in the body weight was significantly larger in the HFD group than in the CD group (P = 0. 0002), CD +n-3PUFAs group (P =0. 0001 ), and HFD + n-3PUFAs group (P =0. 022) . There were significantly more firmicutes ( P = 0. 002) and enterobacteriales ( P = 0. 022 ) and significantly less bacteroidetes ( P = 0. 026) and bifidobactera (P =0. 034) in the gut of rats from HFD group than those from the CD group. There were significantly more bacteroidetes in the fecal samples of the rats from the CD + n-3PUFAs group compared to those from the CD group (P = 0. 043 ) . There were significantly more firmicutes (P = 0. 044) and enterobacte- riales (P--0. 012) and less bacteroidetes (P =0. 042) in the fecal samples of the rats from HFD group com- pared to those from the HFD + n-3PUFAs group. The endotoxin in plasma form portal vein of rats in HFD group were significantly higher than in CD group (P =0. 007) and HFD + n-3PUFAs group (P =0. 042) but showed no significant difference between CD + n-3PUFAs and CD group (P = 0. 210) . Conclusions HFD can in- crease body weight and change gut microbiota. Supplementation of n-3PUFAs can partially counteract such gut dysbiosis, lower endotoxin level in portal vein blood, and improve the body weight.
机构地区 中国医学科学院
出处 《中国医学科学院学报》 CAS CSCD 北大核心 2014年第5期496-500,共5页 Acta Academiae Medicinae Sinicae
基金 黎介寿肠道屏障研究专项资金(LJS_201316) 中国医学科学院北京协和医院青年基金(2009123)~~
关键词 肥胖 高脂饮食 肠道菌群 N-3多不饱和脂肪酸 内毒素 obesity high-fat diet gut microbiota n-3 polyunsaturated fatty acids endotoxin
  • 相关文献

参考文献21

  • 1Chen CM. Overview of obesity in China's Mainland [ J]. Obes Rev, 2008, 9(sl):14-21.
  • 2Nakamura Y, Turin TC, Kita Y, et al. Associations of obe- sity measures with metabolic risk factors in a community-based population in Japan [J]. Circ J, 2007, 71(5) :776-781.
  • 3Qin J, Li R, Raes J, et al. A human gut microbial gene cat- alogue established by metagenomic sequencing [ J]. Nature, 2010, 464(7285) :59-65.
  • 4Bickhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage [ J ]. Proe Nail Acad Sci USA, 2004, 101(44) :15718-15723.
  • 5Tumbaugh PJ, Ley RE, Mahowald MA, et al. An obesity- associated gut microbiome with increased capacity for energy harvest [J]. Nature, 2006, 444(7122):1027-1131.
  • 6Cani PD, Amar J, Iglesias MA, et al. Metabolic endotox- emia initiates obesity and insulin resistance [ J ]. Diabetes, 2007, 56 (7) : 1761-1772.
  • 7Buckley JD, Howe PR. Long-chain omega-3 polyunsaturated fatty acids may be beneficial for reducing obesity-a review [J]. Nutrients, 2010, 2(12):1212-1230.
  • 8Munro IA, Garg ML. Dietary supplementation with long chain omega-3 polyunsaturated fatty acids and weight loss in obese adults [J]. Obes Res Clin Praet, 2013, 7(3) :e173-elS1.
  • 9Zhang C, Zhang M, Wang S, et al. Interactions between gut microbiota, host genetics and diet relevant to developmentof metabolic syndromes in mice [J]. ISME J, 2010, 4(2) : 232-241.
  • 10Qiao Y, Sun J, Xia S, et al. Effects of resveratrol o11 gut mi- crobiota and fat storage in a mouse model with high-fat-induced obesity [J]. Food Funct, 2014, DOI:10. 1039/C3FO60630A.

同被引文献53

  • 1于健春.肥胖症的多学科综合治疗模式[J].中国医学科学院学报,2010,32(1):1-3. 被引量:21
  • 2Rosero O, Kovdcs T, Onody P, et al. Bacterial translocation : gap in the shield[J]. Orv Hetil, 2014, 155(8) :304-312.
  • 3VaishnaviC. Translocation of gut flora and its role in sepsis[J]. Indian J Med Microbiol, 2013, 31(4)334-342.
  • 4BasuS. Neonatal sepsis the gut connection[J]. Eur J ClinMicro- biol Infect Dis, 2015, 34(2)215 222.
  • 5Lin CY, Lee CH, Chang YW, Wang HM, Chen CY, Chen YH. Pheophytin a inhibits inflammation via suppression of LPS- induced nitric oxide synthase 2, kin 11 of macrophages[J]. Int J prostaglandin E2, and interleu MolSci, 2014, 15(12) :22819-22834.
  • 6Li Q,Wang C, Tang C, et al. Bacteremia in patients with acute pancreatitis as revealed by 16S ribosomal RNA gene-based tech- niques[J]. Crit Care, 2013, 41(8) = 1938-1950.
  • 7Sim JS,Kim HS, Oh KJ, et al. Spontaneous bacterial peritonitis with sepsis caused by Enterococcus hirae[J]. J Korean Med Sci, 2012, 27(12):1598 1600.
  • 8van de Veerdonk FL,Joosten LA, NeteaMG. The interplay be- tween inflammasome activation and antifungal host defense[J]. Immunol Rev, 2015, 265(1):172-180.
  • 9Gu GS, Ren JA, Li GW, et al. Cordyceps sinensis preserves in- testinal mucosai barrier and may be an adjunct therapy in endo- toxin-induced sepsis rat mode[: a pilot study[J]. Int J ClinExp Med, 2015, 8(5)7333-7341.
  • 10Gao M,Jiang Y,Xiao X, et al. Protective effect of pioglitazone on sepsis-induced intestinal injury in a rodent model[J]. J Surg Res, 2015, 195(2)550-558.

引证文献5

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部